Skip to Main Content
Yale School of Medicine
YSM Home

INFORMATION FOR

DownloadHi-Res Photo

John K Forrest

MD, FACC, FSCAI
Associate Professor of Medicine (Cardiovascular Medicine); Director of Interventional Cardiology, Cardiovascular Medicine; Program Director for Structural Heart Disease Fellowship, Cardiovascular Medicine; Director of Structural Heart Disease, Yale Medicine; Director, Structural Heart Disease Program, Cardiovascular Medicine

Contact Information

John K Forrest, MD, FACC, FSCAI

Patient Care Location

Mailing Address

  • Cardiovascular Medicine

    PO Box 208017

    New Haven, CT 06520-8017

    United States

Download CV

Related Links

Yale Medicine

Patient Care

Are you a patient?Please visit the Yale Medicine website for information about the services we offer and making an appointment.View Doctor Profile
DownloadHi-Res Photo

Appointments

Education & Training

  • Fellowship
    Yale University School of Medicine (2012)
  • Fellowship
    Yale University (2010)
  • Residency
    Yale-New Haven Hospital/Traditional Program (2008)
  • Internship
    Yale-New Haven Hospital/Traditional Program (2006)
  • MD
    Yale University School of Medicine (2005)
  • BS
    Bowdoin College, History and Biochemistry (1998)

Activities

  • Case Presentation: Bicuspid Tips and Tricks
    Phoenix, AZ, United States 2023
    Transcatheter Valve Therapies Annual Meeting (TVT 2023)
  • Stroke after TAVR: To Protect or Not to Protect?
    Phoenix, AZ, United States 2023
    Transcatheter Valve Therapies Annual Meeting (TVT 2023)
  • Three-Year Outcomes from the Evolut Low Risk Bicuspid Study
    Phoenix, AZ, United States 2023
    Transcatheter Valve Therapies Annual Meeting (TVT 2023)
  • Three-Year Outcomes from the Evolut Low Risk Trial
    Paris, IDF, France 2023
    European Association of Percutaneous Cardiovascular Interventions Annual Meeting (EuroPCR 2023)
  • Transcatheter Versus Surgical Aortic Valve Replacement in Aortic Stenosis Patients at Low Surgical Risk: 3-year Outcomes from the Evolut Low Risk Trial
    Hangzhou, China 2023
    China Valve 2023
  • Computed Tomography to Assess Feasibility of Coronary Access Following Balloon-Expandable Valve Implantation Within a Supra-Annular Transcatheter Valve
    New Orleans, LA, United States 2023
    American College of Cardiology Annual Scientific Session (ACC 2023)
  • Transcatheter vs Surgical Aortic Valve Replacement in Low Risk Patients: 3-Year Outcomes from the Evolut Low Risk Trial
    New Orleans, LA, United States 2023
    American College of Cardiology Annual Scientific Session (ACC 2023)
  • 5-Year Incidence of Bioprosthetic Valve Dysfunction in Patients Randomized to Surgery or TAVI: Insights from the CoreValve US Pivotal and SURTAVI Trials
    Washington, DC, United States 2023
    Cardiovascular Research Technologies Annual Meeting (CRT 2023)
  • Redo-TAVI for Failed Supra-Annular Valves: Analysis of Coronary Flow And Access
    London, England, United Kingdom 2022
    London Valve 2022
  • The Evolut Bioprosthesis Conforms to Elliptical Annuli and Maintains Circularity at the Leaflets
    London, England, United Kingdom 2022
    London Valve 2022
  • Pathological Findings of Self-Expanding Transcatheter Aortic Valves and Hypo-Attenuated Leaflet Thickening (HALT)
    Boston, MA, United States 2022
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2022)
  • EVOLUT: New Trials, New Technologies (OPTIMIZE PRO and SMART)
    Boston, MA, United States 2022
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2022)
  • TAVR and Bicuspid Aortic Valve Disease: Update on the Evidence
    Boston, MA, United States 2022
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2022)
  • Cerebral Embolic Protection in TAVR: Selective use in Vulnerable Patients
    Boston, MA, United States 2022
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2022)
  • The Evolut Supra‐Annular, Self‐Expanding Transcatheter Aortic Bioprosthesis Provides Symmetric Scaffolding for Optimal Leaflet Coaptation Despite Variable Annular Morphology
    Boston, MA, United States 2022
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2022)
  • My "Best Practice’" Routine Bicuspid TAVR
    Miami, FL, United States 2022
    Transcatheter Valve Therapies Annual Meeting (TVT 2022)
  • TAVR in Bicuspid Valves Technical Pearls: Valve Choice, Sizing, and Positioning
    Chicago, IL, United States 2022
    Transcatheter Valve Therapies Annual Meeting (TVT 2022)
  • Progress in Self-Expanding TAVR: Evolut PRO Plus and Beyond
    Chicago, IL, United States 2022
    Transcatheter Valve Therapies Annual Meeting (TVT 2022)
  • Association of Aortoventricular Angulation and Clinical Outcomes After Self-Expanding TAVR
    Atlanta, GA, United States 2022
    Society for Cardiovascular Angiography and Interventions Annual Meeting (SCAI 2022)
  • Impact of Severe Patient-Prosthesis Mismatch in Women with Severe Aortic Stenosis Following Aortic Valve Replacement with a Self-Expanding, Supra-Annular Transcatheter Bioprosthesis or Surgery
    Atlanta, GA, United States 2022
    Society for Cardiovascular Angiography and Interventions Annual Meeting (SCAI 2022)
  • The Role of Transcatheter Aortic Valve Replacement in Low-Flow, Low-Gradient Aortic Stenosis: Insights from the Evolut Low Risk Trial
    Washington, DC, United States 2022
    American College of Cardiology Annual Scientific Session (ACC 2022)
  • Coronary Intervention After Self-Expanding TAVI or SAVR in Low-Risk Patients
    London, England, United Kingdom 2021
    London Valve 2021
  • Two-Year Outcomes Following Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Low Operative Risk Stratified by Need for Revascularization
    Long Eaton, England, United Kingdom 2021
    London Valve 2021
  • Cerebral Embolic Protection and TAVR
    Orlando, FL, United States 2021
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2021)
  • Incidence and Outcomes of Atrial Fibrillation in Patients Undergoing TAVR vs SAVR: Experience from SurTAVI and Low Risk Randomized Studies
    Orlando, FL, United States 2021
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2021)
  • Transcatheter Aortic Valve Replacement in Large Annuli Valves with the Supra-Annular, Self-Expandable Evolut Platform: Insights from the TVT Registry
    Orlando, FL, United States 2021
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2021)
  • TAVR for Bicuspid Aortic Stenosis: Temporal Trends and Outcomes
    Hangzhou, China 2021
    China Valve 2021
  • Between a Rock and a Hard Place: Calcium, Calcium, and More Calcium
    Miami, FL, United States 2021
    Transcatheter Valve Therapies Annual Meeting (TVT 2021)
  • Comparison of 1-Year Outcomes after Transcatheter Aortic Valve Replacement Between Low-Risk Patients with Severe Bicuspid and Tricuspid Aortic Stenosis
    Miami, FL, United States 2021
    Transcatheter Valve Therapies Annual Meeting (TVT 2021)
  • Balancing Contemporary Bicuspid Data
    Miami, FL, United States 2021
    Transcatheter Valve Therapies Annual Meeting (TVT 2021)
  • Complete 2-year Follow-Up from Evolut Low Risk Trial
    Miami, FL, United States 2021
    Transcatheter Valve Therapies Annual Meeting (TVT 2021)
  • Aortic Valve Replacement in Women with Small Aortic Annuli
    Euro PCR 2021 Virtual Conference 2021
    European Association of Percutaneous Cardiovascular Interventions Annual Meeting (Euro PCR 2021)
  • The Evolut Low Risk Trial Complete 2-year Follow-up
    Euro PCI 2021 Virtual Conference 2021
    European Association of Percutaneous Cardiovascular Interventions Annual Meeting (EuroPCR 2021)
  • Impact of Surgical and Transcatheter Aortic Valve Replacement in Symptomatic Patients with Less than Severe Aortic Stenosis
    ACC 2021 Virtual Conference 2021
    American College of Cardiology Annual Scientific Session (ACC 2021)
  • TAVR in Women and Bicuspids
    Virtual Meeting 2021
    PULSE Conference
  • Management of Coronary Disease Pre-and Post TAVR: Guidelines, Tips and Tricks
    On-line Virtual Conference 2020
    Cardiology Grand Rounds
  • Redo Transcatheter Aortic Valve Replacement with the Supra-Annular, Self-Expanding Evolut Platform: Insights from the TVT Registry
    TCT 2020 Virtual 2020
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2020)
  • TAVR Optimization Strategies in Complex Anatomies: Bicuspid
    Virtual Conference 2020
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2020)
  • Updates of Evolut Low Risk Trial
    Hangzhou, China 2020
    China Valve 2020
  • Primary Results of Evolut Low Risk Bicuspid Study
    Hangzhou, China 2020
    China Valve 2020
  • Evolut Platform: Design Features, Outcomes, Implantation Tips and Tricks and Future Visions
    TVT 2020 Virtual Conference 2020
    Transcatheter Valve Therapeutics Annual Meeting (TVT 2020)
  • Blueprint for Bicuspid Treatment: TAVR Implant Strategies for Bicuspid Patients
    Virtual Conference 2020
    Transcatheter Valve Therapeutics Annual Meeting (TVT 2020)
  • Three-Year Outcomes with a Contemporary Self-Expanding Transcatheter Valve in the US- Data from the Evolut PRO US Clinical Study
    SCAI 2020 Virtual Conference 2020
    Society for Cardiovascular Angiography and Interventions Annual Meeting (SCAI 2020)
  • Critical Review of Evidence: TAVR in Low Risk Bicuspid Patients
    Virtual Conference 2020
    Society for Cardiovascular Angiography and Interventions Annual Meeting (SCAI 2020)
  • TAVR Foundations for Fellows
    San Francisco, CA, United States 2019
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2019)
  • TAVR in Bicuspid Aortic Valves
    San Francisco, CA, United States 2019
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2019)
  • TAVR with High Risk for Coronary Obstruction
    San Francisco, CA, United States 2019
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2019)
  • Incidence and Outcomes of Patient-Prosthesis Mismatch Following Self-expanding Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry
    San Francisco, CA, United States 2019
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2019)
  • Latest Clinical Data in Bicuspid Disease
    Chicago, IL, United States 2019
    Transcatheter Valve Therapies Annual Meeting (TVT 2019)
  • Transcatheter Therapies: Potential Realized
    New Orleans, LA, United States 2019
    Cardiology Grand Rounds
  • Valvular Heart Disease in 2019: A Field Transformed
    New Orleans, LA, United States 2019
    Medical Grand Rounds
  • Con: Cerebral Embolic Protection is a Niche Concept
    Las Vegas, NV, United States 2019
    Society for Cardiovascular Angiography and Interventions Annual Meeting (SCAI 2019)
  • New Technologies for Brain Protection During TAVR
    Las Vegas, NV, United States 2019
    Society for Cardiovascular Angiography and Interventions Annual Meeting (SCAI 2019)
  • TAVR in Patients with a Bicuspid Anatomy
    New York, NY, United States 2019
    Global Grand Rounds
  • Self-Expanding Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Bicuspid Morphology: A Report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry
    Washington, DC, United States 2019
    Cardiovascular Research Technologies Annual Meeting (CRT 2019)
  • TAVR Foundations for Fellows
    San Diego, CA, United States 2018
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2018)
  • The Road to Perdition: Severe Aortic Stenosis with Bicuspid Valve Disease
    San Diego, CA, United States 2018
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2018)
  • Paravalvular Leak Post-TAVR
    San Diego, CA, United States 2018
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2018)
  • Coronary Obstruction After TAVR
    San Diego, CA, United States 2018
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2018)
  • 30-Day Outcomes Following Transcatheter Aortic Valve Replacement with the Evolut PRO Valve in Commercial Use: Report from the STS/ACC TVT Registry
    San Diego, CA, United States 2018
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2018)
  • Cerebral Embolic Protection During TAVR
    San Diego, CA, United States 2018
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2018)
  • Structural Heart Disease in 2018: Moving from TAVR to TMVR and More
    Farmington, CT, United States 2018
    Cardiology Grand Rounds
  • Debate: Cerebral Embolic Protection Should be Used in All (Most) Cases
    Chicago, IL, United States 2018
    Transcatheter Valve Therapies Annual Meeting (TVT 2018)
  • The Evolut PRO TAVR System: Confronting the Issues (Valve Sizing, New Pacemakers, Paravalvular Leak, and Extreme Calcification
    Chicago, IL, United States 2018
    Transcatheter Valve Therapies Annual Meeting (TVT 2018)
  • Challenging Structural Cases by the Experts: Predicting and Managing Coronary Obstruction during TAVR
    Orlando, FL, United States 2018
    American College of Cardiology Annual Scientific Session (ACC 2018)
  • 1-Year Outcomes With the Evolut PRO Self-Expanding Repositionable Transcatheter Aortic Valve With Pericardial Wrap
    Orlando, FL, United States 2018
    American College of Cardiology Annual Scientific Session (ACC 2018)
  • Evolut R TAVR - Technology Review Including Evolut 34mm and PRO
    Denver, CO, United States 2017
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2017)
  • Low Incidence of Paravalvular Leak at 6 Months with the New Self-Expanding Repositionable Transcatheter Aortic Valve with Pericardial Wrap
    Denver, CO, United States 2017
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2017)
  • TAVR Shift to Intermediate-Risk Patients: Practical Considerations for the Heart Team and Hospitals
    Denver, CO, United States 2017
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2017)
  • Evolut R Snapshots I - The New Evolut R PRO System
    Chicago, IL, United States 2017
    Transcatheter Valve Therapies Annual Meeting (TVT 2017)
  • Ask the Experts - How Do I Manage These Challenge Case Scenarios?
    Chicago, IL, United States 2017
    Transcatheter Valve Therapies Annual Meeting (TVT 2017)
  • Optimizing Post-Dilation with Self-Expanding Valves - Does Balloon Choice Matter?
    Chicago, IL, United States 2017
    Transcatheter Valve Therapies Annual Meeting (TVT 2017)
  • Will SURTAVI Change my Practice: TAVI for Patients with Intermediate Risk?
    Paris, IDF, France 2017
    European Association of Percutaneous Cardiovascular Interventions Annual Meeting (EuroPCR 2017)
  • Recorded Case: Transcatheter Aortic Valve Replacement using Evolut Pro Valve
    Paris, IDF, France 2017
    European Association of Percutaneous Cardiovascular Interventions Annual Meeting (EuroPCR 2017)
  • Transcatheter Mitral Valve-in-Ring with Concomitant Para-Ring Leak Closure
    Paris, IDF, France 2017
    European Association of Percutaneous Cardiovascular Interventions Annual Meeting (EuroPCR 2017)
  • How to Build a Successful Multidisciplinary Interventional Program: Balancing Pressures of Good Practice and Good Research
    New Orleans, LA, United States 2017
    Society for Cardiovascular Angiography and Interventions Annual Meeting (SCAI 2017)
  • Procedural Perfection: Ideal TAVR Using the Evolut - All the Tips and Tricks
    New Orleans, LA, United States 2017
    Society for Cardiovascular Angiography and Interventions Annual Meeting (SCAI 2017)
  • Managing Complex Paravalvular Leaks
    Atlanta, GA, United States 2017
    Emory Practical Intervention Course Southeastern Consortium (EPIC SEC 2017)
  • 30-Day Safety and Echocardiographic Outcomes Following Transcatheter Aortic Valve Replacement with the Self-Expanding Repositionable Evolut PRO System
    Washington, DC, United States 2017
    American College of Cardiology Annual Scientific Session (ACC 2017)
  • Next Generation TAVI Technologies
    Prague, Prague, Czech Republic 2017
    7th Annual International Therapy and Technology Exchange Program
  • How to Mitigate the Risk of PVL post TAVR
    Prague, Prague, Czech Republic 2017
    7th Annual International Therapy and Technology Exchange Program
  • Transcatheter Aortic Valve Replacement in Women Versus Men: An Analysis of the CoreValve US Pivotal and Continued Access Trials
    San Francisco, CA, United States 2015
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2015)
  • Current Status of TAVR with the Self-Expanding CoreValve System
    Atlanta, GA, United States 2015
    Emory Practical Intervention Course Southeastern Consortium (EPIC SEC 2015)
  • Debate: Is TAVR or SAVR More Appropriate for All Comers: Pro
    Atlanta, GA, United States 2015
    Emory Practical Intervention Course Southeastern Consortium (EPIC SEC 2015)
  • Complex Cases Using a Self-Expanding TAVR
    Atlanta, GA, United States 2015
    Emory Practical Intervention Course Southeastern Consortium (EPIC SEC 2015)
  • US Perspective: Optimizing Patient Selection and Imaging for TAVR
    Washington, DC, United States 2014
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2014)
  • A True Hybrid Case: Off-Pump CABG and TAVR (Direct Aortic Approach using a 31mm CoreValve) in Patient with Left Main Disease, Bicuspid Aortic Valve Stenosis, and Severe Thrombocytopenia
    Washington, DC, United States 2014
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2014)
  • Transcatheter Aortic Valve Replacement in 2014
    New London, CT, United States 2014
    Connecticut Chapter of ACC Annual Meeting (CTACC 2014)
  • Innovation: New Frontier in Implantable Therapies: Clinical Need, Regulatory Challenges, and Market Opportunities
    London, England, United Kingdom 2014
    London Cardiovascular Device Innovation Summit
  • Focus on TAVR: Program, Patient Selections, and Complications
    Medellín, Antioquia, Colombia 2013
    Annual Meeting of Advances in International Cardiovascular Medicine
  • Treating Iliac, SFA, and Critical Limb Ischemia - Patient Screening, Prognosis, Treatment Options and Outcomes
    Medellín, Antioquia, Colombia 2013
    Annual Meeting of Advances in Interventional Cardiovascular Medicine
  • Recorded Case: Retrograde RCA CTO via RV Marginal: The Beating Corsair
    Miami, FL, United States 2012
    Transcatheter Cardiovascular Therapeutics Annual Meeting (TCT 2012)
  • Complex Carotid Stenting
    Orlando, FL, United States 2011
    American Heart Association Science Sessions Conference (AHA 2011)
  • Evaluation of everolimus-eluting and paclitaxel eluting stents in patients with jailed side branches: two-year results from the SPIRIT IV trial
    Paris, IDF, France 2011
    European Society of Cardiology Congress Annual Meeting (ESC 2011)
  • Device Choices for Percutaneous Aortic Paravalvular Leak Closure
    Vancouver, BC, Canada 2011
    Transcatheter Valve Therapies Annual Meeting (TVT 2011)

Honors & Recognition

AwardAwarding OrganizationDate
ACC Emerging Leadership FacultyAmerican College of Cardiology2019
Yale Advanced Emerging Leadership Program2017
Fellow of the American College of CardiologyAmerican College of Cardiology2016
Yale-New Haven Hospital Nurses Choice AwardYale New Haven Hospital2016
Fellow of the Society for Cardiovascular Angiography and InterventionsSociety for Cardiovascular Angiography and Interventions2015
The John P. Peters PrizeYale School of Medicine2005
NIH/NHLBI Student Research Grant AwardNIH/NHLBI2004
Yale Club of New Haven ScholarYale Club of New Haven2001, 2002, 2003, 2004
NIH Summer Research Fellowship AwardNIH2001

Professional Service

OrganizationRoleDate
Yale New Haven Health System Aortic Stenosis Care Signature PathwayCo-Chair2022
PROGRESS (TAVR for Moderate Aortic Stenosis and Cardiac Dysfunction) TrialNational/International Screening Committee2022 - Present
China Valve (Hangzhou)Moderator2022 - Present
Structural Heart Advisory Board, Medtronic IncBoard Member2022 - Present
Structrual Heart Data Evidence and Publications Committee, MedtronicChair2022 - Present
Yale University- Davenport CollegeFaculty Fellow at Davenport College Yale University2021 - Present
HVC Research Leadership CommitteeExecutive Committee Member2021 - Present
Yale New Haven Heath System Lumedx Steering CommitteeCommittee Member2021 - Present
PROGRESS (TAVR for Moderate Aortic Stenosis and Cardiac Dysfunction) TrialNational/International Steering Committee2021 - Present
EVOLUT R Low Risk Randomized Clinical TrialNational/International Principal Investigator2021 - Present
American College of CardiologySTS/ACC TVT Mitral Risk Model Committee2021 - Present
Transcatheter Valve Therapies (TVT)Annual Meeting2021 - Present
New England Structural Heart ConsortiumAnnual Meeting2021 - Present
St. Thomas Day SchoolChairman Board 2021-present2021 - Present
New England Structural Heart ConsortiumAnnual Meeting2021 - Present
New England Structural Heart ConsortiumAnnual Meeting2021 - Present
Journal of American College of Cardiology (JACC)Guest Editor2021 - Present
Journal of the American Medical Association (JAMA)Reviewer2021 - Present
Journal of the Society for Cardiovascular Angiography (JSCAI)Editorial Board Member2021 - Present
Journal of the Society for Cardiovascular Angiography (JSCAI)Reviewer2021 - Present
Yale New Haven Health System Structural Heart Disease Quality Assurance and Performance Improvement Committee Co-Chair2020 - Present
Journal of American College of Cardiology (JACC)Reviewer2020 - Present
JAMA CardiologyReviewer2020 - Present
St. Thomas Day SchoolBoard Vice President2019 - 2021
Society for Cardiovascular Angiography and Interventions (SCAI)Annual Meeting2019 - 2020
Interventional Cardiology Program Evaluation Committee (PEC)Committee Member2019 - Present
Transcatheter Cardiovascular Therapeutics (TCT)Annual Meeting Abstract Review Committee2019 - Present
Society for Cardiovascular Angiography and InterventionsAnnual Meeting2019 - Present
Transcatheter Cardiovascular Therapeutics Abstract Selection Committee2019 - Present
Transcatheter Valve Therapies (TVT)Program Development Committee2019 - Present
Transcatheter Cardiovascular Therapeutics (TCT(Program Development Committee2019 - Present
Transcatheter Cardiovascular Therapeutics (TCT)Program Development Committee2019 - Present
Global Advisory Board, Medtronic IncBoard Member2019 - Present
New England Structural Heart ConsortiumBoard of Directors2018 - Present
BICUSPID TAVR Clinical TrialNational Steering Committee2018 - 2020
BICUSPID TAVR Clinical TrialNational Screening Committee2018 - 2020
REFLECT 3 Clinical TrialNational Screening Committee2018 - 2020
Yale School of Medicine Mission Statement CommitteeCommittee Member2018 - 2019
New England Structural Heart ConsortiumFounding Member2018
BICUSPID TAVR Clinical TrialNational Principal Investigator2018 - Present
APOLLO Transcatheter Mitral Valve Replacement Clinical TrialNational Screening Committee2018 - Present
APOLLO Transcatheter Mitral Valve Replacement Clinical TrialNational Steering Committee2018 - Present
American College of CardiologySTS/ACC TVT TAVR Risk Model Committee2018 - Present
American College of CardiologyAbstract Selection Committee: Aortic Valve Disease2018 - Present
Transcatheter Cardiovascular Therapeutics (TCT)Annual Meeting2018 - Present
Transcatheter Valve TherapiesAnnual meeting (late breaking clinical trials, cases, innovation, moderated posters) reviewer2018 - Present
American College of CardiologyAnnual session Abstract Selection Committee Aorta Valve Disease2018 - Present
New England Structural Heart Annual MeetingCo-Director2018 - Present
Journal of American College of Cardiology - Cardiovascular Interventions (JACC- Intervenions)Reviewer2018 - Present
Quality Committee of the Yale Medicine Board Committee Member2017 - 2019
Yale New Haven Health Systems Quality CommitteeCommittee Member2017 - 2019
Yale Health Shock Team Development CommitteeMember2017 - 2019
American College of CardiologyTVT Dataset Update Working Group2017 - 2019
Yale New Haven Hospital HVC/ED CollaborativeCommittee Member2017 - Present
TAVR UNLOAD Clinical TrialNational Screening Committee2017 - Present
EVOLUT R Low Risk Randomized TAVR TrialNational Steering Committee2017 - Present
Transcatheter Valve Therapies (TVT)Annual Meeting2017 - Present
American College of CardiologyTVT Dataset Update2017 - Present
Transcatheter Valve Therapies (TVT)Abstract Grader 2017 - Present
Transcatheter Cardiovascular TherapiesAnnual meeting Session Chair2017 - Present
Transcatheter Valve TherapiesAbstract Selection Committee2017 - Present
Transcatheter Valve TherapiesAnnual meeting Session Chair2017 - Present
AortaEditorial Board Member2017 - Present
US Advisory Board, Boston ScientificBoard Member2017 - Present
TAVR 2.0 Clinical TrialChair of National Steering Committee2016 - 2018
TAVR 2.0 Clinical TrialChair of National Screening Committee2016 - 2017
Interventional Cardiology Heart Care TeamCommittee Member2016 - Present
TAVR 2.0 Clinical TrialNational Principal Investigator2016 - Present
Structural Heart Advisory Board, Edwards LifesciencesBoard Member2016 - Present
St. Thomas Day SchoolMember Board of Governor's2015 - 2019
FANTOM II Clinical TrialData Safety Monitoring Board (DSMB)2015 - 2018
ABLATE Clinical TrialClinical Event Committee (CEC)2015 - 2016
Yale-New Haven Patient Experience CommitteeCommittee Member2015 - Present
Yale Medical Leadership Committee (MLC/JLC)Committee Member2015 - Present
MedtronicMedtronic Fundamentals of TAVR Fellows Course Co-Director2015 - Present
EdwardsEdwards TAVR Fellows Course Co-Director2015 - Present
MedtronicMedtronic Advanced Users Evolut R Program Co-Chair2015 - Present
American Journal of Cardiology, Catheterization and Cardiovascular InterventionsReviewer2015 - Present
Fundamentals of TAVR, Medtronic IncCo-Director2015 - Present
DEFLECT III Clinical TrialClinical Event Committee (CEC)2014 - 2015
Transcatheter Valve Therapies (TVT)Annual Meeting2014 - Present
DEFLECT II Clinical TrialClinical Event Committee (CEC)2013 - 2014
Transcatheter Cardiovascular Therapeutics (TCT)Annual Meeting2013 - Present
DEFLECT I Clinical TrialClinical Event Committee (CEC)2012 - 2013

Departments & Organizations

Edit Profile